✦ LIBER ✦

Phase II Study of Troxacitabine (BCH-4556) in Patients with Advanced Non-Small-Cell Lung Cancer

✍ Scribed by S.F. Dent; A. Arnold; D.J. Stewart; S. Gertler; J. Ayoub; G. Batist; G. Goss; A. Nevile; D. Soulieres; J. Jolivet; L. Mclntosh; L. Seymour

Publisher: Springer
Year: 2005
Tongue: English
Weight: 76 KB
Volume: 183
Category: Article
ISSN: 0341-2040
DOI: 10.1007/s00408-004-2539-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of gemcitabine and carbop

Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer

✍ Lin Run Wang; Ming Zhu Huang; Guo Bing Zhang; Nong Xu; Xiu Hua Wu 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 385 KB

Phase II study of carboplatin combined w

Phase II study of carboplatin combined with weekly docetaxel in patients with advanced non-small cell lung cancer

✍ Lian Jiang; Dao-yuan Wang; Zhi-hua Zhu; Liang-fa Tang; Xin-heng Hou; Hong-da Zha 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 242 KB

Phase II study of weekly docetaxel combi

Phase II study of weekly docetaxel combined with cisplatin in patients with advanced non-small-cell lung cancer

✍ Toshiyuki Tsunoda; Tomonobu Koizumi; Muneharu Hayasaka; Kazuya Hirai; Shigeru Ko 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 180 KB

Phase II study with fractionated schedul

Phase II study with fractionated schedule of docetaxel and cisplatin in patients with advanced non-small cell lung cancer

✍ Jung Hye Kwon; Jung Han Kim; Jung-Ae Lee; Hyun Chun Shin; Hyo Jung Kim; Hun Ho S 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 193 KB

Phase II study of recombinant beta inter

Phase II study of recombinant beta interferon in patients with advanced non-small-cell lung carcinoma

✍ Ettinger, David S. ;Harwood, Kerry 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB

Eighteen patients with advanced non-smallcell lung cancer (NSCLC) received recombinant beta interferon, 90 million units three times weekly. No complete or partial responses were seen. Five patients had stable disease for several months. Most patients experienced some toxicity, most commonly fever a

Carboplatin and vinblastine in advanced

Carboplatin and vinblastine in advanced non-small-cell lung cancer: a phase II study

✍ D. Doll; M. Goutsou; S. Graziano; J. Ellerton; J. Bitran; C. Modeas; J. Herndon; 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 426 KB